Effects of aging on vasopressin production in a kindred with autosomal dominant neurohypophyseal diabetes insipidus due to the Δe47 neurophysin mutation

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 2, 2002, Pages 870-876

  Patrick Mahoney, C ^a,b   Weinberger, Edward ^b   Bryant, Charles ^a   Ito, Mika ^c   Larry Jameson, J ^a   Ito, Masafumi ^a  

^a Div of Reproductive Endocrinology   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; NEUROPHYSIN; VASOPRESSIN;

ADOLESCENT; ADULT; AGING; ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; DISEASE COURSE; FEMALE; GENE MUTATION; GIANT CELL; HUMAN; HYPERNATREMIA; HYPOTHALAMUS; INFANT; KIDNEY CONCENTRATING CAPACITY; MALE; NEUROHYPOPHYSIS; NEUROHYPOPHYSIS DISEASE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WATER DEPRIVATION;

ADULT; AGING; CHILD; CHILD, PRESCHOOL; DIABETES INSIPIDUS, NEUROGENIC; FEMALE; GENES, DOMINANT; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; NEUROPHYSINS; PEDIGREE; PITUITARY GLAND, POSTERIOR; VASOPRESSINS; WATER DEPRIVATION;

EID: 0036172574     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.2.870     Document Type: Article

References (58)

1. Synthesis, transport and release of posterior pituitary hormones
2. Genetic basis of familial neurohypophyseal diabetes insipidus
3. Functional neuroanatomy and neuropathology of the human hypothalamus
4. A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus
5. A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus
6. Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus
7. Glu-47, which forms a salt bridge between neurophysin-II and arginine vasopressin, is deleted in patients with familial central diabetes insipidus
8. Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation
9. Detection of a novel arginine vasopressin defect by dideoxy fingerprinting
10. A de nove mutation in the coding sequence for neurophysin-II (Pro24 224 Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus
11. Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus
12. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: Cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus
13. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus
14. Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus
15. A new type of familial central diabetes insipidus caused by a single base substitution in the neurophysin II coding region of the vasopressin gene
16. A novel mutation in the coding region for neurophysin-II is associated with autosomal dominant neurohypophyseal diabetes insipidus
17. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala 224 Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor
18. Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly 23 224 Val in neurophysin II
19. Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus
20. Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindreds with familial neurohypophyseal diabetes insipidus
21. Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant
22. Central diabetes insipidus associated with a missense mutation in the arginine vasopressin gene that replaces Ala at the carboxyterminus of the signal peptide with Thr
23. Molecular analysis in familial neurohypophyseal diabetes insipidus: Early diagnosis of an asymptomatic carrier
24. A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus
25. Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin
26. Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation
27. Familial neurohypophyseal diabetes insipidus associated with a novel mutation in the vasopressin-neurophysin II gene
28. On hereditary diabetes insipidus with special regard to a sex-linked form
29. Primary or idiopathic diabetes insipidus: A systemic disease
30. Hereditary idiopathic diabetes insipidus in a case report with autopsy findings
31. Hereditary and idiopathic types of diabetes insipidus
32. Hereditary diabetes insipidus: An immunohistochemical study of the hypothalamus and pituitary gland
33. High-intensity signals within the posterior pituitary fossa: A study with fat-suppression MR techniques
34. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma
35. Fhiorometric liquid-chromatographic determination of serum cortisol
36. A new immunoradiometric assay for corticotrophin evaluated in normal subjects and patients with Cushing syndrome
37. 1-weighted magnetic resonance imaging
38. 1-weighted MR images and vasopressin concentration
39. Hyperintense signal of the posterior pituitary on T-1 weighted MR images: An experimental study
40. Magnetization transfer imaging of the pituitary: Further insights into the nature of the posterior "bright spot"
41. Magnetic resource imaging in familial central diabetes insipidus
42. Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus
43. Central diabetes insipidus in children and young adults
44. Magnetic resonance imaging of posterior pituitary for evaluation of the neurohypophyseal function in idiopathic and autosomal dominant neurohypophyseal diabetes insipidus
45. Frequency and variation of the posterior pituitary bright signal on MR images
46. The human hypothalamo-neurohypophyseal system in relation to development, aging and Alzheimer's disease
47. Characterization of the pituitary gland in elderly subjects from magnetic resonance images: Relationship to pituitary hormone secretion
48. Crystal structure of a bovine neurophysin II dipeptide complex at 2.8A determined from the single-wavelength anomalous scattering signal of an incorporated iodine atom
49. Heterologous expression of human vaso-pressin-neurophysin precursors in a pituitary cell line: Defective transport of a mutant protein from patients with familial diabetes insipidus
50. Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum
51. Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins
52. Mechanism of endoplasmic reticulum retention of mutant vasopressin precursor caused by a signal peptide truncation associated with diabetes insipidus
53. Mutations in the vasopressin prohormone involved in diabetes insipidus impair endoplasmic reticulum export but not sorting
54. Control of release of adrenocorticotropin and vasopressin by the supraoptic and paraventricular nuclei
55. Augmentation of the response to CRF in man: Relative contribution of endogenous angiotensin and vasopressin
56. The relationship of saline-induced changes in vasopressin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man
57. Effect of an osmotic stimulus on the secretion of arginine vasopressin and adrenocorticotropin in the horse
58. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age